Methimazole

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

Volumn 79, Issue , 2001, Pages 53-74

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745978392     PISSN: 02509555     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (97)

1. Aboul-Enein, H.Y. & Al-Badr, A.A. (1979) Methimazole. Anal. Profiles Drug Sitbst., 8, 351-370
2. Ademoglu, E., Gökkusu, C., Yarman, S. & Azizlerli, H. (1998) The effect of methimazole on the oxidant and antioxidant system in patients with hyperthyroidism. Pharmacol. Res., 38, 93-96
3. Akatsuka, K., Hashimoto, T., Takeuchi, K. & Ohhira, M. (1979) [Mutagenicity test of antithyroid agent, methimazole -Dominant lethal mutation test on male mice.] J. toxicol. Sci., 4, 127-138 (in Japanese)
4. Albee, R.R., Mattsson, J.L., Johnson, K.A., Kirk, H.D. & Breslin, W.J. (1989) Neurological consequences of congenital hypothyroidism in Fischer 344 rats. Nenrotoxicol. Teratol., 11, 171-183
5. American Hospital Formulary Service (2000) Methimazole, Bethesda, MD, American Society of Health -System Pharmacists [AHFS First CD-ROM]
6. AOAC International (1998) AOAC Official Method 967.32. Methimazole in Drugs. In: Official Methods of Analysis of AOAC International, 15th Ed., Gaithersburg, MD [CD-ROM]
7. Asakawa, H., Yamasaki, Y., Hanafusa, T., Kono, N. & Tarui, S. (1992) Cell-to-cell communi-cation in cultured rat thyroid monolayer cells is inhibited dose-dependently by methimazole. Res. Commun, ehem. Pathol. Pharmacol., 77, 131-145
8. Azizi, F. (1985) Environmental iodine intake affects the response to methimazole in patients with diffuse toxic goiter. J. din. Endocrinol. Metab., 61, 374-377
9. Azizi, F. (1996) Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. J. Pediatr., 128, 855-858
10. Azizi, F., Khoshniat, M., Bahrainian, M. & Hedayati, M. (2000) Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J. din. Endocrinol. Metab., 85, 3233-3238
11. Batjoens, P., De Brabander, H.F. & De Wasch, K. (1996) Rapid and high-performance analysis of thyreostatic drug residues in urine using as chromatography-mass spectrometry. J. Chromatogr., A., 750, 127-132
12. Bergman, U. & Brittebo, E. (1999) Methimazole toxicity in rodents: Covalent binding in the olfactory mucosa and detection of glial fibrillary acidic protein in the olfactory bulb. Toxicol. appl. Pharmacol, 155, 190-200
13. Bhargava, H.N., Ramarao, P. & Gulati, A. (1988) Effect of methimazole-induced hypothyroidism on multiple opioid receptors in rat brain regions. Pharmacology, 37, 356-364
14. Blanchflower, W.J., Hughes, P.J., Cannavan, A., McCoy, M.A. & Kennedy, D.G (1997) Determination of thyreostats in thyroid and urine using high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. Analyst, 122, 967-972
15. Budavari, S., ed. (2000) The Merck Index, 12th Ed., Version 12:3, Whitehouse Station, NJ, Merck & Co. & Boca Raton, FL, Chapman & Hall/CRC [CD-ROM]
16. Buick, R.K., Barry, C., Traynor, I.M., McCaughey, W.J. & Elliott, C.T. (1998) Determination of thyreostat residues from bovine matrices using high-performance liquid chromatography. J. Chromatogr. B. Biomed. Sci. Appl., 720, 71-79
17. Centrich Escarpenter, F. & Rubio Hernândez, D. (1990) [Analysis of thyrostatics in the thyroid glands by thin layer chromatography and HPLC-UV.] An. Bromatol., 42, 337-344 (in Spanish)
18. CIS Information Services (2000a) Directory of World Chemical Producers (Version 2000.1), Dallas, TX [CD-ROM]
19. CIS Information Services (2000b) Worldvide Bulk Drug Users Directory (Version 2000), Dallas, TX [CD-ROM]
20. Clementi, M., Di Gianantonio, E., Pelo, E., Mammi, I., Basile, R.T. & Tenconi, R. (1999) Methimazole embryopathy: Delineation of the phenotype. Am. J. med. Genet., 83, 43-46
21. Comer, C.P. & Norton, S. (1982) Effects of perinatal methimazole exposure on a develop-mental test battery for neurobehavioral toxicity in rats. Toxicol. appl. Pharmacol., 63, 133-141
22. Comer, C.P. & Norton, S. (1985) Behavioral consequences of perinatal hypothyroidism in postnatal and adult rats. Pharmacol. Biochem. Behav., 22, 605-611
23. Cooke, P.S., Kirby, J.D. & Porcelli, J. (1993) Increased testis growth and sperm production in adult rats following transient neonatal goitrogen treatment: Optimization of the propylthiouracil dose and effects of methimazole. J. Reprod. Fertil, 97, 493-499
24. Cooper, D.S. (1998) Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease. Endocrinol. Metab. Clin. N. Am., 27, 225-247
25. Cooper, D.S. (1999) The side-effects of antithyroid drugs. Endocrinohgist, 9, 457-467
26. Cooper, D.S. (2000) The treatment of hyperthyroidism. In: Braverman, L.E. & Utiger, R.D., eds, Werner & Ingbar 's. Tlie Thyroid. A Fundamental and Clinical Text, 8th Ed., Philadelphia, PA, J.B. Lippincott, pp. 691-715
27. De Brabander, H.F., Batjoens, P. & Van Hoof, J. (1992) Determination of thyreostatic drugs by HPTLC with confirmation by GC-MS. J. planar Chromatogr.-Mod. TLC, 5, 124-130
28. Dobyns, B.M., Sheline, GE., Workman, J.B., Tompkins, E.A., McConahey, W.M. & Becker, D.V. (1974) Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: A report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J. din. Endocrinol. Metab., 38, 976-998
29. Esteve-Romero, J., Escrig-Tena, I., Simô-Alfonso, E.F. & Ramis-Ramos, G (1999) Determination of thyreostatics in animal feed by micellar electrokinetic chromatography. Analyst, 124,125-128
30. Francavilla, S., Cordeschi, G, Properzi, G, Di Cicco, L., Jannini, E.A., Palmero, S., Fugassa, E., Loras, B. & D'Armiento, M. (1991) Effect of thyroid hormone on the pré- and postnatal development of the rat testis. J. Endocrinol., 129, 35-42
31. Gennaro, A.R. (1995) Remington: The Science and Practice of Pharmacy, 19th Ed., Vol. II, Easton, PA, Mack Publishing Co., p. 1086
32. Center, M.B., Deamer, N.J., Blake, B.L., Wesley, D.S. & Levi, P.E. (1995) Olfactory toxicity of methimazole: Dose-response and structure-activity studies and characterization of flavincontaining monooxygenase activity in the Long-Evans rat olfactory mucosa. Toxicol Pathol, 23, 477-486
33. Hallquist, A., Hardell, L., Degerman, A. & Boquist, L. (1994) Thyroid cancer: Reproductive factors, previous diseases, drug intake, family history and diet. A case-control study. Enr. J. Cancer Prev., 3, 481-488
34. Hashimoto, T., Takeuchi, K., Ohno, S. & Komatsu, S. (1987) Mutagenicity tests of the antithyroid agent thiamazole. Cytogenetic studies on male mice. J. toxicol. Sci., 12,23-32
35. Hengstmann, J.H. & Hohn, H. (1985) Pharmacokinetics of methimazole in humans. Klin. Wochenschr., 63, 1212-1217
36. Hood, A., Liu, Y.P., Gattone, V.H.II & Klaassen, C.D. (1999) Sensitivity of thyroid gland growth to thyroid stimulating hormone (TSH) in rats treated with antithyroid drugs. Toxicol. Sci., 49, 263-271
37. Instituto Nacional de Farmacia e do Medicamento (2000) Lisbon
38. Jansson, R., Dahlberg, P.A., Johansson, H. & Lindstrom, B. (1983) Intrathyroidal concentrations of methimazole in patients with Graves' disease. J. din. Endocrinol. Metab., 57, 129-132
39. Jansson, R., Lindström, B. & Dahlberg, P.A. (1985) Pharmacokinetic properties and bioavailability of methimazole. Clin. Pharmacokinet., 10, 443-450
40. Jemec, B. (1970) Studies of the goitrogenic and oncogenic effect of thycapzol on C3H mice. Adapathol. microbiol. scand., 78, 151-160
41. Jemec, B. (1977) Studies of the tumorigenic effect of two goitrogens. Cancer, 40, 2188-2202
42. Johansen, K., Nyboe Andersen, A., Kampmann, J.P., Molholm Hansen, J. & Mortensen, H.B. (1982) Excretion of methimazole in human milk. Eim J. din. Pharmacol., 23, 339-341
43. Kallner, G, Vitols, S. & Ljunggren, J.G (1996) Comparison of standardized initial doses of two antithyroid drugs in the treatment of Graves' disease. J. intern. Med, 239, 525-529
44. Kodama, F., Fukushima, K. & Umeda, M. (1980) Chromosome aberrations induced by clinical medicines. J. toxicol. Sci., 5, 141-149
45. Konishi, N., Kitamura, M., Hayashi, I., Matsuda, H., Tao, M., Naitoh, H., Kitahori, Y. & Hiasa Y. (1995) Effect of methimazole on rat renal carcinogenesis induced by W-ethyl-N-hydroxyethylnitrosamine. Toxicol. Pathol., 23, 606-611
46. Kurata, Y., Wako, Y, Tanaka, K., Inoue, Y. & Makinodan, F. (2000) Thyroid hyperactivity induced by methimazole, spironolactone and phénobarbital in marmosets (Callithrix jacchus): Histopathology, plasma thyroid hormone levels and hepatic T4 metabolism. J. vet. Med. Sci., 62, 607-614
47. Le Bizec, B., Monteau, F., Maume, D., Montrade, MR, Gade, C. & Andre, F. (1997) Detection and identification of thyreostats in the thyroid gland by gas chromatography-mass spectrometry. Anal, chiin. Acta, 340, 201-208
48. Lee, P.W. & Neal, R.A. (1978) Metabolism of methimazole by rat liver cytochrome P-450-containing monoxygenases. Drug Metab. Disposition, 6, 591-600
49. Leer, L.M., Cammenga, M. & De- Vijlder, J.J.M. (1991) Methimazole and propylthiouracil increase thyroglobulin gene expression in FRTL-5 cells. Mol. cell. Endocrinol., 82, R25-R30
50. Lide, D.R. & Milne, GW.A. (1996) Properties of Organic Compounds, Version 5.0, Boca Raton, FL, CRC Press [CD-ROM]
51. Liu, W.K., Tsui, K.W., Lai, K.W.H. & Xie, Y. (1995) Sister-chromatid exchanges in lymphocytes from methimazole-induced hypothyroid mice. Mutât. Res., 326, 193-197
52. Mandel, S.J., Brent, GA. & Larsen, P.R. (1994) Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid, 4, 129-133
53. Martinez-Frîas, M.L., Cereijo, A., Rodriguez-Pinilla, E. & Urioste, M. (1992) Methimazole in animal feed and congenital aplasia cutis [Letter to the Editor]. Lancet, 339, 742-743
54. Masiukiewicz, U.S. & Burrow, GN. (1999) Hyperthyroidism in pregnancy: Diagnosis and treatment. Thyroid, 9, 647-652
55. Medical Products Agency (2000) Uppsala
56. Medicines Evaluation Board Agency (2000) The Hague
57. Meyer-Gessner, M., Benker, G, Lederbogen, S., Olbricht, T. & Reinwein, D. (1994) Antithyroid drug-induced agranulocytosis: Clinical experience with 10 patients in one institution and review of the literature. J. endocrinol. Invest., 17, 29-36
58. Mizutani, T., Murakami, M., Shirai, M., Tanaka, M. & Nakanishi, K. (1999) Metabolismdependent hepatotoxicity of methimazole in mice depleted of glutathione. J. appl. Toxicol., 19, 193-198
59. Momotani, N., Noh, J.Y., Ishikawa, N. & Ito, K. (1997) Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. Endocrinology, 82, 3633-3636
60. Moretti, G, Amici, M. & Cammarata, P. (1986) [Determination of methylthiouracil and analogous thyrostatics in animal tissues by HPTLC after solid-phase purification.] Riv. Soc. ltd. Sci. Aliment., 15, 35-39 (in Italian)
61. Moretti, G, Amici, M., Cammarata, P. & Fracassi, F. (1988) Identification of thyrostatic drug residues in animal thyroids by high-performance thin-layer chromatography and fluorescence reaction detection. J. Chromatogr., 442, 459-463
62. Moretti, G, Betto, R., Cammarata, P., Fracassi, F., Giambenedetti, M. & Borghese, A. (1993) Determination of thyreostatic residues in cattle plasma by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B. Biomed. Sci. Appl., 616,291-296
63. Mortimer, R.H., Cannell, GR., Addison, R.S., Johnson, L.P., Roberts, M.S. & Bernus, I. (1997) Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J. din. Endocrinol. Metab., 82, 3099-3102
64. National Institute for Occupational Safety and Health (2000) National Occupational Exposure Survey 1981-83, Cincinnati, OH, Department of Health and Human Services, Public Health Service
65. Nicholas, W.C., Fischer, R.G, Stevenson, R.A. & Bass, J.D. (1995) Single daily dose of methimazole compared to every 8 hours propylthiouracil in the treatment of hyperthyroidism. South, med. J., 88, 973-976
66. Okamura, K., Ikenoue, H., Shiroozu, A., Sato, K., Yoshinari, M. & Fujishima, M. (1987) Réévaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism. J. din. Endocrinol. Metab., 65, 719-723
67. Owen, N.V., Worth, H.M. & Kiplinger, GF. (1973) The effects of long-term ingestion of methimazole on the thyroids of rats. Food Cosmet. Toxicol., 11, 649-653
68. Paynter, O.E., Burin, GJ., Jaeger, R.B. & Gregorio, C.A. (1988) Goitrogens and thyroid follicular cell neoplasia: Evidence for a threshold process. Regtil. Toxicol. Pharmacol., 8, 102-119
69. Pittman, J., Beschi, R. & Smitherman, T. (1971) Methimazole: Its absorption and excretion in man and tissue distribution in rats. J. din. Endocrinol. Metab., 33, 182-185
70. Prince, J. (2000) Methimazole, the Use of Methimazole (Tepazole) in Dogs and Cats, Rhinelander, WI, Foster & Smith [www.petinfocenter.com/pharmacy/methimazole.htm]
71. Rice, S.A., Millan, O.P. & West, J.A. (1987) The behavioral effects of perinatal methimazole administration in Swiss Webster mice. Fundam. appl. Toxicol., 8, 531-540
72. Romaldini, J.H., Werner, M.C., Bromberg, N. & Werner, R.S. (1991) Adverse effects related to antithyroid drugs and their dose regimen. Exp. din. Endocrinol., 97, 261-264
73. Ron, E., Kleinerman, R.A., Boice, J.D., Jr, LiVolsi, V.A., Flannery, J.T. & Fraumeni, J.F., Jr (1987) A population-based control study of thyroid cancer. J. natl Cancer Inst., 79, 1-12
74. Ron, E., Doody, M.M., Becker, D.V., Brill, A.B., Curtis, R.E., Goldman, M.B., Harris, B.S.H., Hoffman, D.A., McConahey, W.M., Maxon, H.R., Preston-Martin, S., Warshauer, E., Wong, F.L. & Boice, J.D., Jr for the Cooperative Thyrotoxicosis Therapy Follow-up Study Group (1998) Cancer mortality following treatment for adult hyperthyroidism. J. Am. med. Assoc., 280, 347-355
75. Roti, E., Gardini, E., Minelli, R., Salvi, M., Robuschi, G & Braverman, L.E. (1989) Methimazole and serum thyroid hormone concentrations in hyperthyroid patients: Effects of single and multiple daily doses. Ann. intern. Med., Ill, 181-182
76. Royal Pharmaceutical Society of Great Britain (2000) Martindale, The Extra Pharmacopoeia, 13th Ed., London, The Pharmaceutical Press [MicroMedex Online]
77. Sadtler Research Laboratories (1980) Sadtler Standard Spectra, 1980 Cumulative Molecular Formula Index, Philadelphia, PA, p. 36
78. Sargent, K.A., Stopfer, J.E., Mallozzi, A.E., Khandelwal, M., Quashie, C. & Schneider, A.S. (1994) Apparent scalp-ear-nipple (Findlay) syndrome in a neonate exposed to methimazole in utero (Abstract). Am. J. hum. Genetics, 55, A312
79. Sitar, D.S. & Thornhill, O.P. (1973) Methimazole: Absorption, metabolism and excretion in the albino rat. J. Pharmacol. exp. Ther., 184, 432-439
80. 14C]methimazole in the rat. Xenobiotica, 11, 627-634
81. Skellern, GG, Stenlake, J.B. & Williams, W.D. (1973) The absorption, distribution, excretion and metabolism of [2-MC]methimazole in rat. Xenobiotica, 3, 121-132
82. Society of Japanese Pharmacopoeia (1996) The Japanese Pharmacopoeia JP XIII, 13th Ed., Tokyo, pp. 662-663
83. Spanish Medicines Agency (2000) Madrid
84. Stanisstreet, M., Herbert, L.C. & Pharoah, P.O.D. (1990) Effects of thyroid antagonists on rat embryos cultured in vitro. Teratology, 41, 721-729
85. Swiss Pharmaceutical Society (2000) Index Nominum. International Drug Directory, 16th Ed., Stuttgart, Medpharm Scientific Publishers [MicroMedex Online]
86. US Pharmacopeial Convention (1999) The 2000 US Pharmacopeia, 24th revJThe National Formulary, 19th rev., Rockville, MD, pp. 1066-1067, 2278
87. Van der Klauw, M.M., Goudsmit, R., Halie, M.R., van't Veer, M.B., Herings, R.M.C., Wilson, J.H.P. & Stricker, B.H.C. (1999) A population-based case-cohort study of drug-associated agranulocytosis. Arch, intern. Med., 159, 369-374
88. Van Dijke, C.P., Heydendael, R.J. & De Kleine, M.J. (1987) Methimazole, carbimazole, and congenital skin defects. Ann. Intern. Med., 106, 60-61
89. Vargas, G, Havel, J. & Frgalovâ, K. (1998) Capillary zone electrophoresis determination of thyreostatic drugs in urine. J. capillary Electrophor., 5, 9-12
90. Vitug, A.C. & Goldman, J.M. (1985) Hepatotoxicity from antithyroid drugs. Harm. Res., 21, 229-234
91. Vogt, T., Stolz, W. & Landthaler, M. (1995) Aplasia cutis congenita after exposure to methimazole: A causal relationship? Br. J. Dermatol., 133, 994-996
92. Voogd, C.E., van der Stel, J.J. & Jacobs, J.J.J.A.A. (1979) Mutagenic action of nitroimidazoles. IV. A comparison of the mutagenic action of several nitroimidazoles and some imidazoles.
93. Mutât. Res., 66, 207-221
94. Wang, P.-W, Liu, R.-T, Tung, S.-C., Chien, W.-Y., Lu, Y.-C., Chen, C.-H., Kuo, M.-C., Hsieh, J.-R. & Wang, S.-T. (1998) Outcome of Graves' disease after antithyroid drug treatment in Taiwan. J. Formas. Med. Assoc., 97, 619-625
95. Watson, D.G, Bates, C.D., Skellern, GG, Mairs, R. & Martin, S. (1991) Analysis of thiocarbamides by gas chromatography-negative-ion chemical-ionization mass spectrometry. Rapid Commun. Afass Spectrom., 5, 141-142
96. Wiberg, J.J. & Nuttall, F.Q. (1972) Methimazole toxicity from high doses. Ann. intern. Med., 77,414-416
97. Wing, D.A., Millar, L.K., Koonings, P.P., Montoro, M.N. & Mestman, J.H. (1994) A compa-rison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am. J. Obstet. Gynecol., 170, 90-95